Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (L36815)

This article is a response summarizing comments received on Draft LCD MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (L36815) and does not itself establish clinical coverage criteria. For actionable indications, limitations, documentation requirements, and frequency limits, refer to the finalized LCD L36815 (manual review of that LCD is required).